Altered pharmacology and distinct coactivator usage for estrogen receptor-dependent transcription through activating protein-1.
about
Enhanced NF kappa B and AP-1 transcriptional activity associated with antiestrogen resistant breast cancerFunctional interactions between 17 β -estradiol and progesterone regulate autophagy during acini formation by bovine mammary epithelial cells in 3D culturesGenome-wide analysis of estrogen receptor alpha DNA binding and tethering mechanisms identifies Runx1 as a novel tethering factor in receptor-mediated transcriptional activation.A mutant selective anti-estrogen is a pure antagonist on EREs and AP-1 response elements.Skeletal effects of estrogen are mediated by opposing actions of classical and nonclassical estrogen receptor pathwaysCystatin M loss is associated with the losses of estrogen receptor, progesterone receptor, and HER4 in invasive breast cancerTamoxifen increases nuclear respiratory factor 1 transcription by activating estrogen receptor beta and AP-1 recruitment to adjacent promoter binding sitesMultiple sequence-specific DNA-binding proteins mediate estrogen receptor signaling through a tethering pathwayActivation of estrogen receptor α by raloxifene through an activating protein-1-dependent tethering mechanism in human cervical epithelial cancer cells: a role for c-Jun N-terminal kinaseDiverse animal models to examine potential role(s) and mechanism of endocrine disrupting chemicals on the tumor progression and prevention: Do they have tumorigenic or anti-tumorigenic property?The unique transcriptional response produced by concurrent estrogen and progesterone treatment in breast cancer cells results in upregulation of growth factor pathways and switching from a Luminal A to a Basal-like subtypeERα mediates alcohol-induced deregulation of Pol III genes in breast cancer cells.Genomic analysis of estrogen cascade reveals histone variant H2A.Z associated with breast cancer progression.The role of estrogen receptor subtypes in ameliorating hepatic injury following trauma-hemorrhageSupport of a bi-faceted role of estrogen receptor β (ERβ) in ERα-positive breast cancer cellsDifferent modes of enhancer-specific regulation by Runt and Even-skipped during Drosophila segmentation.17β-Estradiol suppresses MHC class I chain-related B gene expression via an intact GC box.Gene expression profiling reveals that the regulation of estrogen-responsive element-independent genes by 17 beta-estradiol-estrogen receptor beta is uncoupled from the induction of phenotypic changes in cell models.Molecular mechanism of estrogen-estrogen receptor signaling.
P2860
Q33281087-A8037096-4D1F-4225-938D-2EF0A293D07BQ33660438-36E0F6F4-3D54-483C-A38D-4812F901C6F3Q34045766-68C66EAC-2352-4340-903C-F83EB92C69BBQ34077765-F19C115B-AEAD-480B-8F31-E03537EF24DBQ34315805-BF1A3B00-C434-484A-BA15-C2A958E3EB5AQ34613588-55C51984-5874-4915-938C-43CFA8F70194Q34682354-ACC6CD03-4426-443F-980D-D76544BDFFA0Q34712109-26478DAE-A3DC-4425-A32C-1AE5D74D2C4DQ35554712-4A1B3127-B382-48D6-8336-A9BE08EE6DF1Q35653376-5BEE6AA7-40C7-4945-942F-F3BF56E538F7Q35820376-F62BFBFF-CD87-4075-ABA2-15244D6F7A6BQ36499775-E17D9C04-B52D-43A3-AFCC-9BC77E13B1F3Q36671809-521A4A4F-5CB7-4098-A2FD-03CF52DEF01EQ36731186-41BB090D-814F-4097-A7E8-A3A9AB229B6CQ37624907-3C045426-CF30-4268-8692-DB1B9EB26591Q37669961-D2535C3F-5C67-4A32-89E0-5DC877AFCEB8Q39175977-1A736F23-16EE-45C1-953C-ABC1ABA59089Q39988677-CFEEE519-DCAB-4AE0-90D6-58C283366717Q47140933-67F31B5F-21C1-48E0-A998-305853A732DD
P2860
Altered pharmacology and distinct coactivator usage for estrogen receptor-dependent transcription through activating protein-1.
description
2005 nî lūn-bûn
@nan
2005 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Altered pharmacology and disti ...... through activating protein-1.
@ast
Altered pharmacology and disti ...... through activating protein-1.
@en
type
label
Altered pharmacology and disti ...... through activating protein-1.
@ast
Altered pharmacology and disti ...... through activating protein-1.
@en
prefLabel
Altered pharmacology and disti ...... through activating protein-1.
@ast
Altered pharmacology and disti ...... through activating protein-1.
@en
P2093
P2860
P356
P1476
Altered pharmacology and disti ...... through activating protein-1.
@en
P2093
Edwin Cheung
Mari Luz Acevedo
Philip A Cole
W Lee Kraus
P2860
P304
P356
10.1073/PNAS.0407113102
P407
P577
2005-01-10T00:00:00Z